Development
Vicarious Surgical Inc.
RBOT
$7.58
-$0.07-0.92%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 16.51% | -2.41% | 43.04% | -140.81% | 54.80% |
| Total Depreciation and Amortization | 17.45% | 1.36% | 0.00% | 9.70% | 18.93% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 525.00% |
| Total Other Non-Cash Items | 208.40% | 22.19% | -119.46% | 288.44% | -172.11% |
| Change in Net Operating Assets | 47.45% | -137.32% | 212.63% | 46.61% | -174.01% |
| Cash from Operations | 34.21% | -14.59% | 18.78% | -0.87% | -33.05% |
| Capital Expenditure | -779.66% | 43.27% | 32.03% | 69.15% | -26.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,256.46% | 91.44% | 85.87% | -- | -- |
| Cash from Investing | 883.39% | 89.87% | 85.50% | -4,318.15% | -26.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 66.67% | 98.68% | -466.46% |
| Issuance of Common Stock | -99.93% | 28,246.99% | 95.29% | -99.15% | 3,740.61% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -100.00% | 166.67% | -- |
| Cash from Financing | -99.92% | 27,204.32% | -40.66% | -96.90% | 8,712.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -123.91% | 223.64% | 65.75% | -486.69% | 27.06% |